OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Oculis Holding AG
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 4, 2026
$7.32+0.03 (+0.41%)
Close on Oct 19, 2026
Share price
−$14.43 (−66.34%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- EPS, diluted
- -1.89 CHF
- Free cash flow
- -CHF 66.61M
Valuation needs the share price. It fills in once daily prices are connected and converted from CHF.
Seven years at a glance
Fiscal years 2019 to 2025, CHF
Operating income
-CHF 81.67M
EPS, diluted
-1.89 CHF
Free cash flow
-CHF 66.61M
Reported period